Literature DB >> 8629304

Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation.

T A Koeppel1, T G Lehmann, J C Thies, R Gehrcke, M M Gebhard, C Herfarth, G Otto, S Post.   

Abstract

Recent observations showed an improvement of hepatic macro- and microhemodynamics as well as survival rates after warm ischemia of the liver following treatment with N-acetylcysteine (NAC). In this study we assessed the influence of NAC on the hepatic microcirculation after orthotopic liver transplantation (OLT) using intravital fluorescence microscopy. OLT with simultaneous arterialization was performed in 16 male Lewis rats following cold storage in University of Wisconsin solution for 24 hr. Within the experimental group (n = 8) donors received NAC (400 mg/kg) 25 min before hepatectomy. In addition, high-dose treatment of recipients with NAC (400 mg/kg) was started with reperfusion. Control animals (n = 8) received an equivalent amount of Ringer's solution. Intravital fluorescence microscopy was performed 30-90 min after reperfusion assessing acinar and sinusoidal perfusion, leukocyte-endothelium interaction, and phagocytic activity. Treatment with NAC reduced the number of nonperfused sinusoid from 52.4 +/- 0.8% to 15.7 +/- 0.5% (p = 0.0001) (mean +/- SEM). Furthermore, we achieved a significant reduction of leukocytes adhering to sinusoidal endothelium (per mm2 liver surface) from 351.9 +/- 13.0 in controls to 83.6 +/- 4.2 in the experimental group (P = 0.0001). In postsinusoidal venules, treatment with NAC decreased the number of sticking leukocytes (per mm2 endothelium) from 1098.5 +/- 59.6 to 425.9 +/- 37.7 (P = 0.0001). Moreover, bile flow was significantly increased after therapy with NAC (4.3 +/- 1.2 vs. 2.2 +/- 0.7 ml/90 min x 100g liver) (P < 0.05). Phagocytic activity was not influenced by application of NAC. We conclude that high-dose therapy with NAC in OLT attenuates manifestations of microvascular perfusion failure early after reperfusion and should be considered as a means to reduce reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8629304     DOI: 10.1097/00007890-199605150-00020

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  Protective effect of andrographolide against concanavalin A-induced liver injury.

Authors:  Guojun Shi; Zhijian Zhang; Rong Zhang; Xiaofang Zhang; Yan Lu; Jian Yang; Di Zhang; Zhiguo Zhang; Xiaoying Li; Guang Ning
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

2.  Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury.

Authors:  Mohammed Reza Moussavian; Claudia Scheuer; Michael Schmidt; Otto Kollmar; Matthias Wagner; Maximilian von Heesen; Martin K Schilling; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-06-27       Impact factor: 3.445

3.  N-acetylcysteine induces shedding of selectins from liver and intestine during orthotopic liver transplantation.

Authors:  F J Taut; H Schmidt; C M Zapletal; J C Thies; C Grube; J Motsch; E Klar; E Martin
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

4.  Protective effects of N-acetylcysteine and Ginkgo biloba extract on ischaemia-reperfusion-induced hepatic DNA damage in rats.

Authors:  Mevlut Sait Keles; Nizamettin Demirci; Abdulkadir Yildirim; Selcuk S Atamanalp; Konca Altinkaynak
Journal:  Clin Exp Med       Date:  2008-09-23       Impact factor: 3.984

5.  N-acetylcysteine administration does not improve patient outcome after liver resection.

Authors:  Stuart M Robinson; Rehan Saif; Gourab Sen; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas; Steven A White
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

6.  Hypotaurine is an Energy-Saving Hepatoprotective Compound against Ischemia-Reperfusion Injury of the Rat Liver.

Authors:  Tadayuki Sakuragawa; Takako Hishiki; Yuki Ueno; Satsuki Ikeda; Tomoyoshi Soga; Ayako Yachie-Kinoshita; Mayumi Kajimura; Makoto Suematsu
Journal:  J Clin Biochem Nutr       Date:  2010-02-27       Impact factor: 3.114

7.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

Review 8.  Factors in the pathophysiology of the liver ischemia-reperfusion injury.

Authors:  Eduardo E Montalvo-Jave; Tomas Escalante-Tattersfield; Jose A Ortega-Salgado; Enrique Piña; David A Geller
Journal:  J Surg Res       Date:  2007-07-27       Impact factor: 2.192

9.  Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances.

Authors:  W Schmidt; A Walther; M M Gebhard; E Martin; H Schmidt
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

10.  Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury.

Authors:  Farin Amersi; Sally K Nelson; Xiu Da Shen; Hirohisa Kato; Judy Melinek; Jerzy W Kupiec-Weglinski; Lawrence D Horwitz; Ronald W Busuttil; Marcus A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.